<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0181093.ref032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Tan</surname>
   <given-names>GS</given-names>
  </name>, 
  <name>
   <surname>Lee</surname>
   <given-names>PS</given-names>
  </name>, 
  <name>
   <surname>Hoffman</surname>
   <given-names>RM</given-names>
  </name>, 
  <name>
   <surname>Mazel-Sanchez</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Krammer</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Leon</surname>
   <given-names>PE</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin</article-title>. 
  <source>Journal of virology</source>. 
  <year>2014</year>;
  <volume>88</volume>(
  <issue>23</issue>):
  <fpage>13580</fpage>â€“
  <lpage>92</lpage>. Epub 2014/09/12. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/JVI.02289-14" xmlns:xlink="http://www.w3.org/1999/xlink">10.1128/JVI.02289-14</ext-link>
  </comment> ; PubMed Central PMCID: PMCPmc4248980.
  <?supplied-pmid 25210195?>
  <pub-id pub-id-type="pmid">25210195</pub-id>
 </mixed-citation>
</ref>
